Minister, it seems to me, anyhow, that part of managing the ongoing COVID pandemic and especially avoiding a further need for shutdowns is doing better at getting out therapeutics for the treatment of COVID. Certainly, studies have shown Paxlovid to be quite effective if given early to high-risk people to prevent progression to more severe disease.
I think that in the supplementaries there is some extra funding for therapeutics. Can you tell me more about that in terms of how much money and for which therapeutics?